Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Aura Biosciences (NASDAQ:AURA) through any online brokerage.
Other companies in Aura Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Aura Biosciences has a consensus price target of $20.80.
The stock price for Aura Biosciences (NASDAQ: AURA) is $6.485 last updated October 7, 2026 at 1:01 PM EDT.
There are no upcoming dividends for Aura Biosciences.
Aura Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Aura Biosciences.
Aura Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.